Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VenomAid Diagnostics is a Danish biotechnology company specializing in the development of rapid, affordable, and easy-to-use diagnostic tools for snakebite envenomation. Spun out from the Technical University of Denmark (DTU), the company has developed a lateral flow assay platform capable of identifying specific snake venoms in minutes using a small blood or wound swab sample. Their lead product is designed to assist clinicians in selecting the correct antivenom, thereby reducing treatment delays and improving patient outcomes in tropical regions. VenomAid's technology addresses a critical gap in global health, particularly in areas where snakebites are a neglected tropical disease with high mortality and morbidity rates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venoma Holdings.